•
Mar 31, 2021

ImmunityBio Q1 2021 Earnings Report

Total Revenue
$139K
Previous year: $165K
-15.8%
EPS
-$0.21
Previous year: -$0.19
+10.5%
Gross Profit
$139K
Previous year: $165K
-15.8%
Cash and Equivalents
$44.7M
Free Cash Flow
-$67.6M
Total Assets
$209M

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment